Advertisement
U.S. Markets closed

scPharmaceuticals Inc. (SCPH)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Visitors trend2W10W9M
4.5300+0.1400 (+3.19%)
At close: 04:00PM EDT
4.5700 +0.04 (+0.88%)
After hours: 05:45PM EDT
Advertisement
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
24,048
13,593
0
0
0
Cost of Revenue
6,937
3,811
0
-
-
Gross Profit
17,111
9,782
0
-
-
Operating Expense
77,494
65,178
36,157
25,823
29,933
Operating Income
-60,383
-55,396
-36,157
-25,823
-29,933
Net Non Operating Interest Income Expense
-4,420
-3,019
-2,099
-2,526
-2,272
Other Income Expense
4,159
3,605
1,418
315
-4
Pretax Income
-60,644
-54,810
-36,838
-28,034
-32,209
Net Income Common Stockholders
-60,644
-54,810
-36,838
-28,034
-32,209
Diluted NI Available to Com Stockholders
-60,644
-54,810
-36,838
-28,034
-32,209
Basic EPS
-1.36
-1.42
-1.30
-1.02
-1.31
Diluted EPS
-1.36
-1.42
-1.30
-1.02
-1.31
Basic Average Shares
36,638
38,514
28,359
27,352
24,569
Diluted Average Shares
36,638
38,514
28,359
27,352
24,569
Total Operating Income as Reported
-60,383
-55,396
-36,157
-25,823
-29,933
Total Expenses
84,431
68,989
36,157
25,823
29,933
Net Income from Continuing & Discontinued Operation
-60,644
-54,810
-36,838
-28,034
-32,209
Normalized Income
-60,644
-54,810
-36,838
-28,034
-32,209
Interest Income
3,967
5,104
1,203
49
315
Interest Expense
8,387
8,123
3,302
2,575
2,587
Net Interest Income
-4,420
-3,019
-2,099
-2,526
-2,272
EBIT
-52,257
-46,687
-33,536
-25,459
-29,622
EBITDA
-51,742
-46,061
-33,068
-25,021
-29,223
Reconciled Cost of Revenue
6,937
3,811
0
-
-
Reconciled Depreciation
515
626
468
438
399
Net Income from Continuing Operation Net Minority Interest
-60,644
-54,810
-36,838
-28,034
-32,209
Normalized EBITDA
-51,742
-46,061
-33,068
-25,021
-29,223
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0